BCLI Message Board Post 9191248 | Brainstorm Cell...
home / stock / bcli / bcli message board
precisionairgunammo
(investorshub)
Posted on: Oct/13/2022 19:16:04
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170190958
https://alsnewstoday.com/news/als-biomarkers-boosted-nurown-regardless-disease-s
News, Short Squeeze, Breakout and More Instantly...
Brainstorm Cell Therapeutics Inc. Company Name:
BCLI Stock Symbol:
Market:
Brainstorm Cell Therapeutics Inc. Website:
-
BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation Canada NewsWire FROM ACF EQUITY RESEARCH HEALTHCARE TEAM NASDAQ: BCLI READ ACF EQUITY RESEARCH'S...
-
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn PR Newswire The data will be presented at the Annual ALS Drug Development Summit, which is focused on identifying transformative ALS targets, see...
-
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire Company received written agreement from the U.S. FDA under a Special Protocol Assessment (SPA) on the design for a Phase 3b trial of NurOwn® C...